neohesperidin dihydrochalcone,
neohesperidine DC,
neohesperidine dihydrochalcone,
neohesperidin dihydrochalcone,
20702-77-6,
Nhdc,
Neohesperidin dc,
Neohesperidin dhc,
Neohesperidine,
NCI-C60764,
Neosperidin dihydrochalcone,
UNII-3X476D83QV,
CCRIS 4848,
EINECS 243-978-6,
Neohesperidine dihydrochalcone,
CHEBI:83535,
3X476D83QV,
Neohesperidin Dihydrochalcone (Nhdc),
1-(4-((2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,6-dihydroxyphenyl)-3-(3-hydroxy-4-methoxyphenyl)propan-1-one,
1-(4-((2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,6-dihydroxyphenyl)-3-(3-hydroxy-4-methoxyphenyl)-,
1-Propanone, 1-(4-((2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,6-dihydroxyphenyl)-3-(3-hydroxy-4-me,
3,5-Dihydroxy-4-(3-hydroxy-4-methoxyhydrocinnamoyl)phenyl) 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside,
Glucopyranoside, 3,5-dihydroxy-4-(3-hydroxy-4-methoxyhydrocinnamoyl)phenyl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-, beta-D-,
1-[4-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2,6-dihydroxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)propan-1-one,
Glucopyranoside, 3,5-dihydroxy-4-(3-hydroxy-4-methoxyhydrocinnamoyl)phenyl-2-O-(6-deoxy-alpha-L-mannopyranosyl)-, beta-D-,
1-Propanone, 1-(4-((2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,6-dihydroxyphenyl)-3-(3-hydroxy-4-methoxyphenyl)-,
C28H36O15,
Neosperidin-dihydrochalcone,
DSSTox_CID_5706,
AC1L1J2O,
Neohesperidin-dihydrochalcone,
DSSTox_RID_77887,
DSSTox_GSID_25706,
SCHEMBL909958,
CHEMBL1159645,
DTXSID3025706,
ITVGXXMINPYUHD-CUVHLRMHSA-,
ITVGXXMINPYUHD-CUVHLRMHSA-N,
Neohesperidin-dihydrochalcone(Nhdc),
1-(4-((2-O-[6-Deoxy-alpha-L-mannopyranosyl]-beta-D-glucopyranosyl)oxy)-2,6-dihydroxyphenyl)-3-[3-hydroxy-4-methoxyphenyl]-1-propanone,
HY-N0154,
ZINC4175639,
Tox21_200303,
CN-448,
LS-995,
MFCD00017711,
s2331,
AKOS015895239,
CS-6419,
NCGC00091109-01,
NCGC00091109-02,
NCGC00091109-04,
NCGC00257857-01,
AS-15190,
O413,
SC-47053,
Neohesperidin dihydrochalcone, >=96%, FG,
CAS-20702-77-6,
N0675,
Neohesperidin dihydrochalcone, >=95% (HPLC),
Neohesperidin dihydrochalcone, analytical standard,
702N776,
SR-01000883756,
Q-201457,
SR-01000883756-1,
BRD-K61032563-001-02-9,
roxyphenyl)-3-(3-hydroxy-4-methoxyphenyl)propan-1-one,
Neohesperidin dihydrochalcone, European Pharmacopoeia (EP) Reference Standard,
Neohesperidin dihydrochalcone, United States Pharmacopeia (USP) Reference Standard,
1-(4-(((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-2,6-dihyd,
1-(4-(((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-2,6-dihydroxyphenyl)-3-(3-hydroxy-4-methoxyphenyl)propan-1-one,
1-(4-((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-2,6-dihydroxyphenyl)-3-(3-hydroxy-4-methoxyphenyl)propan-1-one,
1-[4-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5,
1-[4-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-2,6-dihydroxy-phenyl]-3-(3-hydroxy-4-methoxy-phenyl)propan-1-one,
1-Propanone,1-[4-[[2-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-2,6-dihydroxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)-,
3,5-dihydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]phenyl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside,
InChI=1/C28H36O15/c1-11-21(34)23(36)25(38)27(40-11)43-26-24(37)22(35)19(10-29)42-28(26)41-13-8-16(32)20(17(33)9-13)14(30)5-3-12-4-6-18(39-2)15(31)7-12/h4,6-9,11,19,21-29,31-38H,3,5,10H2,1-2H3/t11-,19+,21-,22+,23+,24-,25+,26+,27-,28+/m0/s1,
Neohesperidin,
Citrosa,
neohesperidine DC,
CID30231,
ACN-035679,
C28-H36-O15,
C013613,
1-Propanone, 1-[4-[[2-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2,6-dihydroxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)-,
Neohesperidin dihydrochalcone, 99%, from Citrus maxima - 100MG 100mg,
1-[4-[[2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,6-dihydroxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)propan-1-one,
1-propanona, 1-[4-[[2-o-(6-deoxi-?-l-manopiranosil)-?-d-glucopiranosil]oxi]-2,6-dihidroxifenil]-3-(3-hidroxi-4-metoxifenil)-,
Glucopyranoside, 3,5-dihydroxy-4-(3-hydroxy-4-methoxyhydrocinnamoyl)phenyl 2-O-(6-deoxy-.alpha.-L-mannopyranosyl)-, .beta.-D-,